Technology | 2016.01.31
Technology Evaluation Consortium™ Evaluated a New Transition Regulating Technology for Drug Resistance in Cancer Therapy as INNOVATOR via Signature Square™ Program
The designation of Innovator was bestowed upon Wayne State University’s CaCy Therapeutics’ translation regulating technology for drug resistance in cancer therapy via the One Million Solutions in Health Signature Square™ program after an evaluation by members of the Technology Evaluation Consortium.
(PRWeb January 30, 2016)
Read the full story at http://www.prweb.com/releases/2016/02/prweb13191935.htm
For more information, please visit
http://www.prweb.com/releases/2016/02/prweb13191935.htm
